Transmedics Group Inc (TMDX) Stock Analysis
Verdict: WATCH (do not buy)
Warm perfusion monopoly drives strong top-line growth, but two consecutive EPS misses and high beta (2.14) threaten near-term performance.
Investment score: 57/100
Analysis as of
Is Transmedics Group Inc stock worth reviewing? AI model thesis
TransMedics maintains a near-monopolistic hold on warm organ perfusion technology, driving revenue expansion toward consensus $740M in 2026. However, recent earnings misses and margin compression from logistics investments justify a HOLD stance until profitability stabilizes.
7-factor investment score
- Valuation: 62/100 (weight 20%)
- Financial Health: 78/100 (weight 15%)
- Technical Momentum: 58/100 (weight 15%)
- Earnings Quality: 38/100 (weight 15%)
- Insider Sentiment: 45/100 (weight 10%)
- Analyst Consensus: 68/100 (weight 10%)
- Risk-Adjusted Return: 48/100 (weight 15%)
Transmedics Group Inc opportunities and risks
What speaks for TMDX
- Organ Care System (OCS) technological monopoly in warm perfusion
What speaks against TMDX
- Earnings miss trajectory and cost inflation from logistics expansion
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| TMDX | 19.8x | 4.5x | 28.5x | 58.7% | 22.7% | 2.6% |
| ITGR | 34.2x | 2.3x | 18.0x | 23.7% | 7.0% | 2.6% |
| NVST | 42.3x | 1.4x | 11.6x | 55.5% | 3.3% | 5.7% |
| IRTC | n/a | 4.5x | 206.7x | 71.5% | -1.7% | 1.1% |
| PLSE | n/a | 2897.5x | n/a | -21.6% | -6755.8% | -1.8% |
| ATRC | 269.3x | 5.1x | 103.5x | 76.2% | 1.9% | 2.0% |
| Peer median | 34.2x | 4.5x | 18.0x | 55.5% | 1.9% | 2.0% |
Frequently asked questions about Transmedics Group Inc (TMDX)
Is TMDX stock a good investment?
The cached TradeMates AI model rates Transmedics Group Inc as WATCH (do not buy) with an investment score of 57/100. TransMedics maintains a near-monopolistic hold on warm organ perfusion technology, driving revenue expansion toward consensus $740M in 2026. However, recent earnings misses and margin compression from logistics investments justify a HOLD stance until profitability stabilizes. This is algorithmic model output, not personal investment advice.
Is TMDX stock a buy?
The TradeMates model verdict for TMDX is WATCH (do not buy) with an investment score of 57/100. Treat this as a model signal to review, not a personal buy recommendation.